Edition:
United States

Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

648.60INR
3:54am EDT
Change (% chg)

Rs3.90 (+0.60%)
Prev Close
Rs644.70
Open
Rs648.80
Day's High
Rs656.30
Day's Low
Rs640.80
Volume
556,640
Avg. Vol
920,404
52-wk High
Rs1,129.05
52-wk Low
Rs555.00

Latest Key Developments (Source: Significant Developments)

Wockhardt, units settle commercial litigation with Teva Pharma, Cephalon
Thursday, 22 Jun 2017 06:49am EDT 

June 22 (Reuters) - Wockhardt Ltd ::Says co, units settle with teva and its affiliate a commercial litigation in high court, london.Says commercial litigation in relation to supply contract for a drug named trisenox.Says CP has agreed to waive its claim for outstanding trade receivable of GBP 20 mln .CP dropped its counterclaim for GBP 20 mln and further paid a sum of GBP 23 mln to Teva and Cephalon by way of full and final settlement of Teva's claims.  Full Article

Wockhardt says Irish HPRA grants certificate of GMP compliance to Shendra facility
Monday, 29 May 2017 02:19am EDT 

May 29 (Reuters) - Wockhardt Ltd :Says Health Products Regulatory Authority of Ireland has granted certificate of GMP compliance to Shendra, Aurangabad facility.Says certificate based on inspection performed from 27th February, 2017 to 3rd March, 2017.  Full Article

Wockhardt March-qtr loss widens
Thursday, 4 May 2017 08:45am EDT 

May 4 (Reuters) - Wockhardt Ltd :March quarter consol net loss 1.74 billion rupees.March quarter consol total income 9.20 billion rupees.Consol net loss in March quarter last year was 53.8 million rupees as per Ind-AS; consol total income was 10.28 billion rupees.Says board approved issue of NCDs on pvt placement basis up to 12 billion rupees.Says approved raising of funds by way of equity shares up to INR 10 billion.Says growth in UK in current year remained subdued due to polito-economic adversities.  Full Article

Wockhardt receives USFDA acknowledgement for phase III clinical trial of WCK 5222
Monday, 3 Apr 2017 01:46am EDT 

Wockhardt Ltd : Says Wockhardt receives acknowledgement of its breakthrough superdrug antibiotic WCK 5222 for phase iii clinical trial from us fda . Says WCK 522 is a comibination of Zidebactaqm and Cafepime .Says WCK 5222 is used for treatment of pneumonia.  Full Article

Wockhardt's unit gets FDA nod for piperacillin and tazobactam for injection
Tuesday, 21 Mar 2017 07:49am EDT 

Wockhardt Ltd : Says FDA approved ANDA of piperacillin and tazobactam for injection usp, 40.5 g/vial, pharmacy bulk package submitted by co's unit .ANDA was determined to be therapeutically equivalent to reference listed drug (RLD) Zosyn for injection 40.5g/vial.  Full Article

Wockhardt says HPRA inspected co's Shendra, Aurangabad facility
Tuesday, 7 Mar 2017 07:18am EST 

Wockhardt Ltd : Says HPRA inspected co's Shendra, Aurangabad facility .Says recommended renewal of certificate based on general compliance with principles and guidnelines of good manufacturing practice.  Full Article

Wockhardt Ltd gets USFDA warning letter for co's stepdown unit
Wednesday, 1 Mar 2017 07:11am EST 

Wockhardt Ltd : Says USFDA issued a warning letter to Morton Grove Pharmaceuticals Inc., USA, a stepdown subsidiary of company . Says current portfolio of company will continue to be made available in market . Says new approvals will be withheld till resolution .Says company has already initiated appropriate measures since last several months to address the issues raised by USFDA.  Full Article

Pharmadax signs license contract with Wockhardt
Wednesday, 1 Feb 2017 09:29pm EST 

Pharmadax Inc <4191.TWO> : Says it signed contract with Wockhardt Bio AG, Switzerland, for a blood pressure lowering generic drug product .After the company getting FDA approval, Wockhardt will sell the product in USA and the company will receive milestone payment of $2 million and share profits with Wockhardt.  Full Article

Wockhardt Ltd posts Dec qtr consol loss
Tuesday, 24 Jan 2017 06:05am EST 

Wockhardt Ltd : Wockhardt Ltd - dec quarter consol net loss 539.1 million rupees . Wockhardt Ltd - dec quarter consol net sales 9.96 billion rupees . Wockhardt Ltd - consol net profit in dec quarter last year was 720.4 million rupees as per Ind-AS; consol net sales was 10.75 billion rupees .Wockhardt Ltd says performance during quarter was affected by subdued business in U.S. Market, demonetization in India and continued remediation costs.  Full Article

Wockhardt Ltd approves acquisition of stake in Wockhardt France (Holdings)
Thursday, 10 Nov 2016 08:08am EST 

Wockhardt Ltd :Wockhardt Ltd says approved acquisition of 100% stake in Wockhardt France (Holdings) S.A.S. from Wockhardt Bio AG.  Full Article

BRIEF-KPC Pharma to signs MOU with Swiss firm Wockhardt on sales of insulin related products in China

* Says it plans to signs MOU with Switzerland's Wockhardt on sales of insulin-related products in China